130 related articles for article (PubMed ID: 2551913)
1. Managing patients after cardiac transplantation.
Hunt HA; Schroeder JS
Hosp Pract (Off Ed); 1989 Oct; 24(10):83-7, 90-6, 99-100. PubMed ID: 2551913
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations.
Harris KM; Schwartz ML; Slasky BS; Nalesnik M; Makowka L
Radiology; 1987 Mar; 162(3):697-700. PubMed ID: 3544033
[TBL] [Abstract][Full Text] [Related]
3. Early results of cardiac transplantation at the Texas Heart Institute.
Reece IJ; Frazier OH; Painvin A; Okereke OJ; Chandler LB; Krudewig TW; Cooley DA
Thorax; 1984 Sep; 39(9):676-80. PubMed ID: 6382676
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of cyclosporine-based immunosuppression in cardiac transplantation: the Loyola experience.
Costanzo-Nordin MR; Grady KL; Johnson MR; Winters GL; Ventura HO; Pifarré R
Transplant Proc; 1990 Jun; 22(3 Suppl 1):6-11. PubMed ID: 2349737
[No Abstract] [Full Text] [Related]
5. Lymphoproliferative disorder of nasopharynx after long-standing cyclosporin therapy for psoriatic arthritis.
Leong AC; Yong J; Salama N
J Laryngol Otol; 2010 Oct; 124(10):1120-2. PubMed ID: 20370953
[TBL] [Abstract][Full Text] [Related]
6. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
[TBL] [Abstract][Full Text] [Related]
7. Heart transplantation: limitations and perspectives.
Struck E; Hagl S; Meisner H; Sebening F
Z Kardiol; 1985; 74 Suppl 6():59-63. PubMed ID: 3913181
[TBL] [Abstract][Full Text] [Related]
8. Cardiac transplantation. Selection, immunosuppression, and survival.
Stevenson LW; Laks H; Terasaki PI; Kahan BD; Drinkwater DC
West J Med; 1988 Nov; 149(5):572-82. PubMed ID: 3074557
[TBL] [Abstract][Full Text] [Related]
9. Clinical orthotopic cardiac transplantation.
Slater AD; Klein JB; Gray LA
Am J Surg; 1987 Jun; 153(6):582-93. PubMed ID: 3296808
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression.
Braunlin EA; Hunter DW; Canter CE; Gutierrez FR; Ring WS; Olivari MT; Titus JL; Spray TL; Bolman RM
Circulation; 1991 Nov; 84(5 Suppl):III303-9. PubMed ID: 1657452
[TBL] [Abstract][Full Text] [Related]
11. Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation.
Moore CK; Bristow MR; Renlund DG; Rasmussen LG; O'Connell JB
Transplant Proc; 1990 Jun; 22(3 Suppl 1):25-9. PubMed ID: 2349736
[No Abstract] [Full Text] [Related]
12. Heart transplantation. Long-term management related to immunosuppression, complications, and psychosocial adjustments.
Augustine SM
Crit Care Nurs Clin North Am; 2000 Mar; 12(1):69-77. PubMed ID: 11051920
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine in cardiac transplantation.
Goldman MH; Barnhart G; Mohanakumar T; Wetstein L; Szentpetery S; Wolfgang TC; Lower RR
Surg Clin North Am; 1985 Jun; 65(3):637-59. PubMed ID: 3898434
[TBL] [Abstract][Full Text] [Related]
14. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database.
Russo MJ; Chen JM; Hong KN; Stewart AS; Ascheim DD; Argenziano M; Mancini DM; Oz MC; Naka Y;
Circulation; 2006 Nov; 114(21):2280-7. PubMed ID: 17088463
[TBL] [Abstract][Full Text] [Related]
15. Cardiac transplantation with corticosteroid-free immunosuppression: long-term results.
Lee KF; Pierce JD; Hess ML; Hastillo AK; Wechsler AS; Guerraty AJ
Ann Thorac Surg; 1991 Aug; 52(2):211-7; discussion 218. PubMed ID: 1863141
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
17. Long-term assessment of renal function under cyclosporine in pediatric heart transplant recipients.
Robitaille P; Chartrand S; Stanley P; Chartrand C
J Heart Lung Transplant; 1991; 10(3):460-2; discussion 463. PubMed ID: 1854774
[TBL] [Abstract][Full Text] [Related]
18. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy.
Beveridge T; Krupp P; McKibbin C
Lancet; 1984 Apr; 1(8380):788. PubMed ID: 6143097
[No Abstract] [Full Text] [Related]
19. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.
Uretsky BF; Murali S; Reddy PS; Rabin B; Lee A; Griffith BP; Hardesty RL; Trento A; Bahnson HT
Circulation; 1987 Oct; 76(4):827-34. PubMed ID: 3308166
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine in heart and heart-lung transplantation.
Modry DL; Oyer PE; Jamieson SW; Stinson EB; Baldwin JC; Reitz BA; Dawkins KD; McGregor CG; Hunt SA; Moran M
Can J Surg; 1985 May; 28(3):274-80, 282. PubMed ID: 3922606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
